In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 80278-67-7, name is Isoquinoline-5-carbaldehyde, introducing its new discovery. SDS of cas: 80278-67-7
KINASE INHIBITORS
The present invention relates to new AGC kinase inhibitors, in particular to compounds of Formula (I) or (II) or a stereoisomer, tautomer, racemic, metabolite, pro- or predrug, salt, hydrate, or solvate thereof, wherein R1, R2, R4, R5, R7, R8, q s, L, and Y have the meaning defined in the claims. In particular, the present invention relates to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 80278-67-7, and how the biochemistry of the body works.SDS of cas: 80278-67-7
Reference£º
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem